Evidence map›Paper›PMID 39052216›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

Drug Screening Using Normal Cell and Cancer Cell Mixture in an Automated 3D Cell Culture System.

Mathew C Carson, Peng Xu, John J Gildea, Collin F Marino, Robin A Felder

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mathew C CarsonDepartment of Pathology, University of Virginia Health System, Charlottesville, VA, USA.
Peng XuDepartment of Pathology, University of Virginia Health System, Charlottesville, VA, USA.
John J GildeaDepartment of Pathology, University of Virginia Health System, Charlottesville, VA, USA.
Collin F MarinoDepartment of Pathology, University of Virginia Health System, Charlottesville, VA, USA.
Robin A FelderDepartment of Pathology, University of Virginia Health System, Charlottesville, VA, USA. robin@virginia.edu.

Funding

Spatiotemporal transregulation of D1-like angiotensin receptors in genetically...P01HL074940 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GILDEA, JOHN JOSEPH · 2004 to 2020
$31.8M
NHLBI NIH HHS P01 HL074940
6 · The paper itself

Abstract

Three-dimensional (3D) cell culture creates a more physiologically relevant environment for enhanced drug screening capabilities using microcarriers. An automated 3D system that integrates robotic manipulators, liquid handling systems, sensors, and environment control systems has the capacity to handle multiple samples in parallel, perform repetitive tasks, and provide real-time monitoring and analysis. This chapter describes a potential 3D cell culture drug screening model by combining renal proximal tubule cells as a representative normal cell line with cancer cell lines. This combination is subjected to drug screening to evaluate the drug's efficacy in suppressing cancer cells while minimizing impact on normal cells with the added benefit of having the ability to separate the two cell types by magnetic isolation for high content screens including mass spectrometry-based proteomics. This study presents advancements in 3D cell culture techniques, emphasizing the importance of automation and the potential of microcarriers in drug screening and disease modeling.

Indexed as

Cell Culture Techniques, Three DimensionalAntineoplastic AgentsAutomationAutomation, LaboratoryCell Culture TechniquesCell Line, TumorDrug Evaluation, PreclinicalDrug Screening Assays, AntitumorHumansKidney Tubules, ProximalNeoplasmsAntineoplastic Agents3D cell cultureAutomationCancer cellsMicrocarrierRenal proximal tubule cells

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.